Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 3 years.
Collegium Pharmaceutical Inc.
Director
Zevra Therapeutics Inc.
Director · President and CEO
Chief executive roles
Zevra Therapeutics Inc.
· President and CEO
Since October 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 14, 2025 | Zevra Therapeutics Inc. | Open-market sale | −30,544 | $8.05 | $245,879 |
| Feb 13, 2025 | Zevra Therapeutics Inc. | Open-market sale | −61,273 | $7.86 | $481,606 |
| Jan 31, 2025 | Zevra Therapeutics Inc. | Option exercise | +233,333 | — | — |
| May 16, 2024 | Collegium Pharmaceutical Inc. | Grant or award | +7,693 | — | — |
| May 18, 2023 | Collegium Pharmaceutical Inc. | Grant or award | +9,792 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.